N,N'-Di-[5'-deoxy-5'-N-methyl-N'-(4-butyryl)-adenosine]-1,6-diaminohexane

ID: ALA1939723

Chembl Id: CHEMBL1939723

PubChem CID: 57395442

Max Phase: Preclinical

Molecular Formula: C36H56N14O8

Molecular Weight: 812.93

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(CCCC(=O)NCCCCCCNC(=O)CCCN(C)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C36H56N14O8/c1-47(15-21-27(53)29(55)35(57-21)49-19-45-25-31(37)41-17-43-33(25)49)13-7-9-23(51)39-11-5-3-4-6-12-40-24(52)10-8-14-48(2)16-22-28(54)30(56)36(58-22)50-20-46-26-32(38)42-18-44-34(26)50/h17-22,27-30,35-36,53-56H,3-16H2,1-2H3,(H,39,51)(H,40,52)(H2,37,41,43)(H2,38,42,44)/t21-,22-,27-,28-,29-,30-,35-,36-/m1/s1

Standard InChI Key:  MFEJXSLVZJXWLU-VCJUVLFBSA-N

Associated Targets(non-human)

metJ Met repressor (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 812.93Molecular Weight (Monoisotopic): 812.4406AlogP: -1.71#Rotatable Bonds: 21
Polar Surface Area: 303.30Molecular Species: BASEHBA: 20HBD: 8
#RO5 Violations: 3HBA (Lipinski): 22HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.17CX Basic pKa: 8.69CX LogP: -2.63CX LogD: -4.68
Aromatic Rings: 4Heavy Atoms: 58QED Weighted: 0.04Np Likeness Score: 0.03

References

1. Joce C, White R, Stockley PG, Warriner S, Turnbull WB, Nelson A..  (2012)  Design, synthesis and in vitro evaluation of novel bivalent S-adenosylmethionine analogues.,  22  (1): [PMID:22137339] [10.1016/j.bmcl.2011.11.017]

Source